A solution? Paul Chapman (GM Takeda pharma)
Competitive advantage in industry comes from making better judgements based on all available data and using it to create better molecules; everything else can and should be shared.
How to optimise this knowledge for drug discovery and development ? How to exploit consortia ?
Our solutions are to use experts from many different fields to give open recommendations on the state of a new area and to clearly indicate what we don’t know and where the variables are.
Create consortia with multidisciplinary experts for serious diseases.
This has enabled a major breakthrough in ALS.